BOSTON, Sept. 23, 2009 — The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to host its October conference on Off-Label Information, taking place at the Sheraton National Hotel, Arlington, VA, on October 22-23, 2009. This conference, now in its 11th year, has become the leading event for senior-level executives in Regulatory, Compliance, Legal and Medical Affairs departments. Executives share strategies and experiences to compliantly disseminate scientific information and mitigate the risks surrounding off-label promotion.
Highlights of the 2009 agenda include:
- An FDA Keynote Address on the new guidance for industry on presenting risk information in prescription drug and medical device promotion
- Prosecutor views of the Eli Lilly and Pfizer settlements
- Assessment of the high-risk areas for MSLs and strategies to strengthen their role in the scientific exchange of information
- Today’s top considerations of promotional review committees
- Real-time monitoring of off-label prescribing
CBI’s events are meticulously organized and driven by industry feedback. With major regulatory developments in this area and a heightened enforcement landscape, this year’s meeting is especially timely.
For more information on this event, please visit: http://www.cbinet.com/offlabel
For press inquiries, please contact Monali Shah of CBI at 339.298.2285 or email: m.shah@cbinet.com
About CBI:
A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy- and decision-makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit http://www.cbinet.com.
# # #
